Ville Saint-Laurent, Canada Clinical Trials

A listing of Ville Saint-Laurent, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 46 clinical trials
Intra-articular Vancomycin Powder in Knee and Hip Arthroplasty

The purpose of this study is to compare infection rates when patients, elected for primary or aseptic revision THA / TKA, have a single intravenous antibiotic dose versus one single intravenous antibiotic dose in combination with intra-articular antibiotics. This is a prospective, randomized clinical survey on selected outcome measurements on …

osteonecrosis
vancomycin
antibiotics
total knee replacement
antibiotic therapy
Hopital Sacr -Coeur de Montreal
 (2.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
An Open-label Ascending Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)

Primary Objective: To describe the pharmacokinetic (PK) profile of sarilumab in patients aged 2-17 years with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) in order to identify the dose and regimen for adequate treatment of this population Secondary Objective: To describe the pharmacodynamic (PD) profile, the efficacy and the long-term safety of …

anti-rheumatic drugs
disease modifying antirheumatic drugs
arthritis
rheumatoid factor
antirheumatic
Investigational Site Number 1240112
 (6.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +33 other locations
An Efficacy and Safety Study of Ravulizumab in ALS Participants

The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.

edaravone
ravulizumab
riluzole
vaccination
Montreal Neurological Institute and Hospital
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer

Prostate cancer is the second most common cancer among Canadian men of which approximately 20-30% present with high-risk tumour characteristic. Although surgery can be curative in patients evidencing pathological high-risk disease (extracapsular extension, seminal vesicle involvement, positive surgical margins), a large proportion will develop biochemical failure within years from the …

adenocarcinoma of prostate
prostatectomy
digital rectal examination
white blood cell count
digital rectal exam
McGill University Health Centre- Cedars Cancer Centre
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.

The objective of this trial is to study the efficacy of treatment of human papilloma virus (HPV) related oropharyngeal cancer with chemotherapy followed by Transoral Robotic Surgery (TORS) as definitive treatment. Current treatment of oropharyngeal cancer are chemo-radiotherapy. There is significant lifelong side effects associated with this approach related to …

primary tumor
oropharyngeal
chemo-radiotherapy
carcinoma
papilloma
McGill University Health Centre
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
The TARGET-EFT Trial

Randomized clinical trial to determine whether a multicomponent intervention will lead to improvements in mobility, self-care, mood, pain, and physical activity among frail and pre-frail older adults (as measured with the Essential Frailty Toolset; EFT) hospitalized for an acute cardiovascular illness.

malnutrition
anemia
Jewish General Hospital
 (5.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Evaluate the Safety Pharmacokinetics and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

This is a Phase I dose-escalation and dose-expansion study that will evaluate the safety, pharmacokinetics (PK), and preliminary activity of GDC-6036 in patients with advanced or metastatic solid tumors with a KRAS G12C mutation.

kras
kras g12c mutation
solid tumor
metastatic malignant solid tumor
ki-ras
Jewish General Hospital; Sir Mortimer B. Davis
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +7 other locations
Adenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate Cancer

This is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of AB928-based combination therapy in participants with metastatic castrate resistant prostate cancer (mCRPC).

measurable disease
antiandrogens
testosterone
castration-resistant prostate cancer
combination therapy
Centre hospitalier de l'Universit de Montr al (CHUM) Centre de Recherche
 (9.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +21 other locations
Targeting Risk Factors for Diabetes in Subjects With Normal Blood Cholesterol Using Omega-3 Fatty Acids

Every 3 minutes a new case of diabetes is diagnosed in Canada, mostly type 2 diabetes (T2D) increasing the risk for heart disease. T2D and heart disease share many common risk factors such as aging, obesity and unhealthy lifestyle. Paradoxically however, while lowering blood LDL, commonly known as "bad cholesterol", …

omega-3 fatty acids
insulin
fish oil
diabetes
fatty acids
Montreal Clinical Research Institute
 (8.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Pompe Disease Registry

The Pompe Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Pompe disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The objectives …

glycogen storage disease type ii
myozyme
replacement therapy
deficiency
gaa gene
Investigational Site Number 124004
 (8.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +190 other locations